Actively Recruiting
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Led by Glaukos Corporation · Updated on 2026-01-21
132
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
CONDITIONS
Official Title
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically significant age-related cataract eligible for phacoemulsification in the study eye
- Diagnosis of open-angle glaucoma (primary, pseudoexfoliation, or pigmentary) or ocular hypertension in the study eye
You will not qualify if you...
- Active corneal inflammation or edema
- Retinal disorders not associated with glaucoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Glaukos Investigator Site
Kenosha, Wisconsin, United States, 53142
Actively Recruiting
Research Team
S
Study Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here